Consortium Researchers

The following are researchers who are actively involved in IRC5 research endeavours & participate in at least one working group.

Members

  • Glena Andrews, neuropsychology, George Fox University, Oregon, USA
  • *Tania Attié-Bitach, molecular genetics and fetal pathology, Necker-Enfants Malades Hospital and Imagine Institute, University Paris Descartes, Paris, France
  • *Rhonda Booth, pediatric neuropsychology, University of London, London, England
  • *Warren Brown, neuropsychology, Fuller Graduate School of Psychology, Pasadena, USA
  • Alain Chedotal, molecular genetics, Institut de la Vision, Paris, France
  • *Christel Depienne, clinical genetics, University Hospital Essen, Essen, Germany
  • Catherine Garel, neuroradiology, Hôpital d’Enfants Armand-Trousseau, Paris, France
  • Kim Giraudat, neuropsychology, Hôpital d’Enfants Armand-Trousseau, Paris, France
  • Orit Glenn, neonatal radiologist, University of California, San Francisco, USA
  • Delphine Heron, clinical genetics, Groupe Hospitalier Pitié-Salpêtrière, University Pierre et Marie Curie, Paris, France
  • Gregor Kasprian, neuroradiology, Medical University of Vienna, Austria
  • Emmanuelle Lacaze, neuropsychology, Hôpital d’Enfants Armand-Trousseau, Paris, France
  • Roberto Lent, neuroscience, Federal University of Rio de Janeiro, Brazil
  • Tally Lerman-Sagie, pediatric neurology, Pediatric Neurology Unit, Wolfson Medical Center, Israel
  • Richard Leventer, pediatric neurology, Royal Children’s Hospital, Melbourne, Australia
  • Marco Leyton, behavioral neuroscience, McGill University, Montreal, Canada
  • *Paul Lockhart, molecular genetics, Murdoch Children’s Research Institute, Melbourne, Australia
  • *Simone Mandelstam, pediatric neuroradiology, Florey Neurosciences, Melbourne, Australia
  • Cyril Mignot, pediatric neurology & neurogenetics, Groupe Hospitalier Pitié-Salpêtrière et Hôpital Trousseau, Paris, France
  • Marta Nieto-Lopez, molecular neurodevelopment, Centro Nacional de Biotecnología, Madrid, Spain
  • *Lynn K. Paul, neuropsychology & cognitive neuroscience, Caltech, Los Angeles, USA
  • *Linda J. Richards, molecular neurodevelopment, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Gail Robinson, clinical neuropsychology, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Romina Romaniello, child neuropsychiatry, Eugenio Medea Scientific Institute, Bosisio Parini, Lecco, Italy
  • *Elliott H. Sherr, pediatric neurology & neurogenetics, University of California, San Francisco, USA
  • Victor Tarabykin, molecular neurodevelopment, Charite University Hospital, Berlin, Germany
  • *Fernanda Tovar-Moll, neuroradiology, Federal University of Rio de Janeiro & D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Mark Walterfang, neuropsychiatry, Royal Melbourne Hospital, Melbourne, Australia
  • *Binnaz Yalcin, genetics, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France

*currently on Governance Board of Directors

Affiliates

  • Emanuela Argilli, University of California, San Francisco, USA
  • Filippo Arrigoni, Scientific Institute, Eugenio Medea Scientific Institute, Bosisio Parini, Lecco, Italy
  • Nadia Bahi-Buisson,  Necker-Enfants Malades Hospital and INSERM U1163 – Imagine Institute, Paris, France
  • Nathalie Boddaert, Necker-Enfants Malades Hospital, Paris, France
  • Lucile Boutaud, Imagine Institute, Paris, France
  • Ivanei Bramati, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Jens Bunt, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Ryan Dean, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Jessica Dubios, INSERM U1141, Robert-Debré Hospital, Gif-sur-Yvette, France
  • Timothy Edwards, Queensland Brain Institute and Faculty of Medicine, University of Queensland, Brisbane, Australia
  • Ferechte Encha-Razavi, Necker-Enfants Malades Hospital, Paris, France
  • Laura Fenlon, Queensland Brain Institute, Brisbane, Australia
  • Sonia Garel, Institut de Biologie de l’Ecole Normale Superieure, Paris, France
  • Lucas Gemal, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Juliette Godin, IGBMC, Illkirch, France
  • Soveig Heide, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
  • Ruiji Jiang, University of California, San Francisco, USA
  • David Kahn, Caltech, Los Angeles, USA
  • Dorit Kliemann, Caltech, Los Angeles, USA
  • Zorana Lynton, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Theo Marins, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Ashley Marsh, University of California, San Diego, USA
  • Bruno de Melo, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Anne Elodie Millisher, Necker-Enfants Malades Hospital, Paris, France
  • Ching Moey, The University of Queensland, Queensland Brain Institute, Brisbane, Australia
  • Jorge Moll, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Myriam Monteiro, D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
  • Marie Laure Moutard, Hôpital d’Enfants Armand-Trousseau, Paris, France
  • Remya Nair, Caltech, Los Angeles, USA
  • Alessandra Pierrani, Imagine Institute, Paris, France
  • Natalia Rich-Wimmer, George Fox University, Oregon, USA
  • Laurent Salomon, Hospital Necker-Enfants Malades & Imagine Institute, Paris, France
  • Vanessa Siffredi, University of Geneva & EPFL, Geneva, Switzerland
  • Myrtille Spentchian, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
  • Diego Szczupak, NIH NINDS CMU, Bethesda, Maryland, USA
  • Sophie Thomas, INSERM U1163 – Imagine Institute, Paris, France
  • Jasmin Turner, Caltech, Los Angeles, USA
  • Stéphanie Valence, Hôpital d’Enfants Armand-Trousseau, Paris, France
  • Alice Wright, University College London, England